Inhibition of TRPV4/calcium/NF-κB signaling pathway attenuates hepatic oxidative stress and inflammatory injury.The combination of TM and HAL has great potential for the treatment of hepatocellular carcinoma by reducing tumour hypoxia and angiogenesis. Here, NFKB1 is linked to hepatocellular carcinoma.